SILO - Psyched: Ramaswamy Psychedelics For PTSD UK Clinical Trials Johns Hopkins Q&A And More | Benzinga
GOP Candidate Vivek Ramaswamy Wants Legal Psychedelics And Cannabis For PTSD In New Veterans Plan
Vivek Ramaswamy, who famously said he did not approve of Ohio’s cannabis initiative last week despite expressing support for federal legalization, is now saying that if elected he will remove federal restrictions on marijuana and psychedelics. He says he wants to take a "a holistic approach” especially to help veterans during and after their time in service.
"As President, I will take a holistic approach to ensure Veterans receive the care they need to live long, flourishing lives — starting during their service and continuing in the decades that follow,” according to Ramaswamy’s plan, which his campaign released on Veterans Day in New Hampshire. More HERE.
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
The U.K. Medicines and Healthcare Regulatory Agency (MHRA) has green-lighted two separate Phase 3 trials conducted by Compass Pathways (NASDAQ: CMPS) for Treatment-Resistant Depression and Awakn Life Sciences (OTCMKTS: AWKNF) for Severe Alcohol Use Disorder (SAUD). More on both trials HERE.
Johns Hopkins Psychedelics Professors: Q&A: Knowns, Unknowns, Regulations & Hopes
Johns Hopkins University’s new congressional briefings series chapter, "What’s next for psychedelics,” covered a wide range of topics including clinical research specificities, therapists' training, policy hurdles, potential economic impact and necessary safeguards.
The session was led by Frederick Barrett, ...